Fermenta Biotech Ltd

Established in 1951, DIL Limited (earlier known as Duphar-Interfran Limited) is a publicly-listed company that has developed a unique standing in the businesses of pharmaceuticals, biotechnology, environmental solutions and other segments.(Source : 201983 Annual Report Page No: 6)

Pros:
Company has good consistent profit growth of 21.80% over 5 years
Cons:
Stock is trading at 9.55 times its book value
Company has low interest coverage ratio.
Company has a low return on equity of -17.12% for last 3 years.

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs

Loading peers table ...

Quarterly Results Standalone Figures in Rs. Crores / View Consolidated

Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019
1 1 2 3 3 5 5 121 5 5 5 81
4 4 4 4 4 10 4 84 4 4 4 65
Operating Profit -3 -3 -2 -1 -1 -5 0 37 1 1 2 16
OPM % -265% -193% -133% -27% -32% -112% 8% 31% 18% 18% 29% 19%
Other Income 0 0 0 0 0 0 0 9 0 0 0 5
Interest 1 1 2 3 2 4 4 5 4 4 4 5
Depreciation 1 1 1 1 1 1 1 3 1 1 1 4
Profit before tax -5 -5 -5 -5 -4 -10 -4 39 -4 -4 -3 12
Tax % -5% -2% -0% -0% -0% -7% -0% 30% -0% 573% 35% -168%
Net Profit -5 -5 -5 -5 -4 -10 -4 27 -4 19 -2 33
EPS in Rs -5.36 -5.25 -5.34 -5.44 -4.23 -2.81 -4.80 28.43 -4.38 20.68 -2.43 33.97
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
9 12 21 15 18 18 15 14 6 6 13 19 96
6 8 10 10 7 9 11 11 13 14 22 19 77
Operating Profit 3 4 11 5 11 9 4 3 -6 -8 -9 0 19
OPM % 35% 36% 51% 34% 60% 50% 28% 21% -106% -154% -75% 1% 20%
Other Income 1 2 1 23 9 0 0 0 1 0 0 -6 5
Interest 0 1 0 0 0 0 0 0 2 6 11 16 17
Depreciation 1 1 1 1 2 2 2 2 2 3 4 4 7
Profit before tax 3 4 10 27 18 7 2 1 -9 -18 -23 -26 1
Tax % 4% 17% 26% 20% 20% 20% 31% 30% 1% -2% -3% 90%
Net Profit 3 3 8 22 15 5 1 1 -9 -18 -24 -3 45
EPS in Rs 2.40 3.08 7.69 22.66 14.77 4.88 1.12 0.54 0.00 0.00 0.00 0.00 47.84
Dividend Payout % 88% 101% 45% 26% 47% 96% 161% 157% -6% -3% -2% -43%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:4.71%
5 Years:4.96%
3 Years:46.61%
TTM:-28.03%
Compounded Profit Growth
10 Years:0.95%
5 Years:21.80%
3 Years:34.24%
TTM:422.21%
Stock Price CAGR
10 Years:23.61%
5 Years:29.57%
3 Years:45.66%
1 Year:-40.63%
Return on Equity
10 Years:-2.02%
5 Years:-11.55%
3 Years:-17.12%
Last Year:6.07%

Balance Sheet Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
2 2 2 2 2 2 2 2 2 2 2 5
Reserves 68 67 71 86 93 92 91 90 80 87 62 55
Borrowings 0 0 0 2 6 1 25 35 52 44 143 147
10 11 12 9 9 13 13 16 15 12 15 27
Total Liabilities 80 81 85 99 110 108 131 143 149 146 223 233
10 13 13 13 12 10 8 7 93 94 96 93
CWIP 1 0 0 0 5 13 34 63 1 1 0 0
Investments 51 49 47 59 36 32 39 40 41 40 118 108
18 19 25 27 57 53 51 34 15 12 9 33
Total Assets 80 81 85 99 110 108 131 143 149 146 223 233

Cash Flows Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
8 5 -5 -3 31 11 2 -0 -5 -9 1 16
-7 -3 9 12 -25 -2 -20 -11 -8 20 -89 0
-1 -2 -4 -8 -7 -8 21 9 14 -13 88 -16
Net Cash Flow 0 0 -0 1 -0 1 2 -2 1 -2 1 -0

Ratios Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 4% 8% 14% 12% 10% 7% 2% 1% -5% -9% -7% -2%
Debtor Days 128 88 23 31 5 12 9 5 2 26 8 5
Inventory Turnover 81.78 40.04 33.76 30.04 27.29